S81041 |
Raltegravir Potassium Salt |
源叶(MedMol) | 99% |
- 提示:详情请下载说明书。
- 产品描述: Raltegravir (MK 0518) potassium is a potent integrase (IN) inhibitor, used to treat HIV infection.
- 靶点: HIV Integrase;HIV;HIVProtease; Integrase
- 体内研究:
Raltegravir induces viro-immunological improvement of nonhuman primates with progressing SIVmac251 infection. One non-human primate shows an undetectable viral load following Raltegravir monotherapy
- 参考文献:
1. Hare, S., et al., Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance. Proc Natl Acad Sci U S A, 2010. 107(46): p. 20057-62. 2. Hicks C, et al. Raltegravir: the first HIV type 1 integrase inhibitor. Clin Infect Dis. 2009 Apr 1;48(7):931-9 3. Moss DM, et al. Divalent metals and pH alter raltegravir disposition in vitro. Antimicrob Agents Chemother. 2012 Jun;56(6):3020-6 4. Hare S, et al. Structural and functional analyses of the second-generation integrase strand transfer inhibitor dolutegravir (S/GSK1349572). Mol Pharmacol. 2011 Oct;80(4):565-72. 5. Lewis, M.G., et al. Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy. Retrovirology, 2010. 7: p. 21.
- 溶解性: H2O : 25 mg/mL (51.81 mM; Need ultrasonic) DMSO : 20.83 mg/mL (43.17 mM; ultrasonic and warming and heat to 60°C)
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 2.072 ml 10.362 ml 20.725 ml 5 mM 0.414 ml 2.072 ml 4.145 ml 10 mM 0.207 ml 1.036 ml 2.072 ml 50 mM 0.041 ml 0.207 ml 0.414 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)